Jacobs Levy Equity Management, Inc Myriad Genetics Inc Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $1.25 Million - $1.99 Million	-62,922 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $8.65 Million - $14.1 Million	-711,567 Reduced 91.88%	62,922 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $7.26 Million - $9.52 Million	645,116 Added 498.65%	774,489 $10.1 Million
Q2 2020 Aug 17, 2020	BUY	$10.69 - $16.49 $1.38 Million - $2.13 Million	129,373 New	129,373 $1.47 Million
Q3 2017 Nov 14, 2017	SELL	$24.01 - $36.2 $1.58 Million - $2.39 Million	-65,900 Closed	0 $0
Q2 2017 Nov 09, 2017	BUY	N/A	65,900	65,900 $1.7 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.